临床外科杂志 ›› 2026, Vol. 34 ›› Issue (5): 529-533.doi: 10.3969/j.issn.1005-6483.20241392

• 论著 • 上一篇    下一篇

血清单核细胞趋化蛋白-1、NOD样受体蛋白3联合检测早期预测重症急性胰腺炎并发急性肾损伤的价值

  

  1. 550014  贵州贵阳,北京积水潭医院贵州医院外科
  • 收稿日期:2024-08-22 接受日期:2024-08-22 出版日期:2026-05-20 发布日期:2026-05-20
  • 基金资助:
    贵州省卫生健康委科学技术基金项目(GZWKJ2023-373)

The early predictive value of combined detection of serum monocyte chemotactic protein-1 and NOD like receptor protein 3 in severe acute pancreatitis with acute kidney injury

  1. Department of Surgery,Beijing Jishuitan Hospital Guizhou Hospital,Guizhou,Guiyang 550014,China
  • Received:2024-08-22 Accepted:2024-08-22 Online:2026-05-20 Published:2026-05-20

摘要: 目的 探讨重症急性胰腺炎并发急性肾损伤病人血清单核细胞趋化蛋白-1(MCP-1)、NOD样受体蛋白3(NLRP3)表达水平变化及二者联合对疾病早期预测价值。方法 2022年5月~2024年5月收治重症急性胰腺炎病人105例为观察组,根据是否合并急性肾损伤分为未并发组(69例)和并发组(36例),并根据急性肾损伤病情程度进一步分为轻度组(15例)、中度组(12例)和重度组(9例)。另选择同期体检健康志愿者105例为对照组。采用酶联免疫吸附试验(ELISA)法对血清MCP-1、NLRP3表达水平进行检测;多因素Logistic分析重症急性胰腺炎病人并发急性肾损伤的影响因素;绘制受试者工作特征(ROC)曲线分析血清MCP-1、NLRP3水平预测重症急性胰腺炎病人并发急性肾损伤的价值。结果 对照组血清MCP-1、NLRP3表达水平分别为(118.24±24.68)μg/L和(267.42±61.24)μg/L,观察组病人分别为(407.46±101.73)μg/L和(603.23±164.51)μg/L,两组比较差异有统计学意义(P<0.05),并发组血清MCP-1、NLRP3表达水平分别为(482.59±102.99)μg/L和(755.33±143.73)μg/L,未并发组分别为(368.26±76.29)μg/L和(523.88±110.10)μg/L,两组比较差异有统计学意义(P<0.05);随着急性肾损伤病情程度的进展,轻度组、中度组和重度组病人血清MCP-1表达水平分别为(378.23±48.08)μg/L、(521.22±39.52)μg/L、(605.03±26.20)μg/L;血清MCP-1表达水平分别为(629.89±67.88)μg/L、(764.99±45.26)μg/L、(951.52±80.97)μg/L,均依次升高,差异有统计学意义(P<0.05);多因素Logistic分析结果表明,肌酐、MCP-1、NLRP3是影响重症急性胰腺炎并发急性肾损伤的危险因素(P<0.05);ROC曲线分析结果表明,血清MCP-1、NLRP3水平二者联合预测重症急性胰腺炎病人并发急性肾损伤的曲线下面积(AUC)为0.943。结论 重症急性胰腺炎并发急性肾损伤病人血清MCP-1、NLRP3表达水平升高,二者联合早期预测急性肾损伤效能较高。

关键词: 重症急性胰腺炎, 急性肾损伤, 单核细胞趋化蛋白-1, NOD样受体蛋白3, 预测

Abstract: Objective To investigate the changes in the expression levels of serum monocyte chemotactic protein-1 (MCP-1) and NOD like receptor protein-3 (NLRP3) in patients with severe acute pancreatitis complicated by acute kidney injury,and the early predictive value of the combination of the two for diseases.Methods A total of 105 patients with severe acute pancreatitis from May 2022 to May 2024 were selected as the observation group.They were separated into a non concurrent group of 69 cases and a concurrent group of 36 cases based on whether acute kidney injury was present.According to the severity of acute kidney injury,they were further grouped into a mild group of 15 cases,a moderate group of 12 cases,and a severe group of 9 cases.Additionally,105 healthy volunteers who underwent physical examination were regarded as the control group.Enzyme linked immunosorbent assay (ELISA) was applied to detect the expression levels of serum MCP-1 and NLRP3.Multi factor Logistic analysis was applied to analyze the influencing factors of acute kidney injury in patients with severe acute pancreatitis.Receiver operating characteristic (ROC) curve was plotted to analyze the predictive value of serum MCP-1 and NLRP3 levels in predicting acute kidney injury in patients with severe acute pancreatitis.Results Serum MCP-1 and NLRP3 expression levels in the control group were (118.24±24.68) μg/L and (267.42±61.24) μg/L,respectively,while those in the observation group were (407.46±101.73) μg/L and (603.23±164.51) μg/L,respectively,with statistically significant differences between the two groups (P<0.05).In the concurrent group,serum MCP-1 and NLRP3 levels were (482.59±102.99) μg/L and (755.33±143.73) μg/L,respectively,compared with (368.26±76.29) μg/L and (523.88±110.10) μg/L in the non concurrent group,showing statistically significant differences (P<0.05).As the severity of acute kidney injury progressed,the serum MCP-1 expression levels in the mild,moderate,and severe groups were (378.23±48.08) μg/L,(521.22±39.52) μg/L,and (605.03±26.20) μg/L,respectively;The expression levels of serum MCP-1 were (629.89±67.88) μg/L,(764.99±45.26) μ g/L,and (951.52±80.97) μg/L,respectively,all of which increased in sequence with statistically significant differences.Multivariate Logistic analysis showed that creatinine,MCP-1,and NLRP3 were risk factors for severe acute pancreatitis complicated with acute kidney injury (P<0.05).ROC results showed that the area under the curve (AUC) value of serum MCP-1 and NLRP3 levels combined to predict acute kidney injury in patients with severe acute pancreatitis was 0.943.Conclusion The expression levels of serum MCP-1 and NLRP3 are elevated in patients with severe acute pancreatitis complicated by acute kidney injury,and the combination of the two has a higher efficacy in early prediction of acute kidney injury.

Key words: severe acute pancreatitis, acute kidney injury, monocyte chemotactic protein-1, NOD like receptor protein 3, prediction

[1] 刘阳 李斌 尹天圣 张雅军. 手术标本磷脂酶Cε1 mRNA、Src同源结构域3蛋白1 mRNA、细胞周期蛋白依赖性激酶12 mRNA联合预测胃癌内镜黏膜下剥离术后早期病情进展的增益价值[J]. 临床外科杂志, 2026, 34(5): 513-517.
[2] 于敏 秦研然. 胃底体积大小、营养状况及幽门梗阻对胃癌根治术后并发胃瘫综合征风险的预测价值[J]. 临床外科杂志, 2026, 34(5): 523-528.
[3] 王楠 余鸿 李建刚. 重症急性胰腺炎继发胸腔积液风险列线图预测模型的建立与验证[J]. 临床外科杂志, 2026, 34(5): 539-543.
[4] 阮月璐 黄林飞 朱磊 刘倩 刘健. 结直肠癌原发灶中范可尼蛋白表达与术后早期复发转移的关系[J]. 临床外科杂志, 2026, 34(5): 562-566.
[5] 罗桂芝 邹琦 杨又专 马红超. 基于机器学习算法构建回肠造口病人脱水风险预测模型及验证[J]. 临床外科杂志, 2026, 34(4): 416-421.
[6] 吴腾啸 王嘉毅 李尧. 腹腔镜联合胆道镜术后胆总管结石复发的危险因素分析及预测模型构建[J]. 临床外科杂志, 2026, 34(3): 296-300.
[7] 陈红 李菲菲 彭思芹 俞荷花. 重症急性胰腺炎并发左侧门静脉高压症的危险因素及列线图预测模型构建[J]. 临床外科杂志, 2026, 34(3): 301-305.
[8] 杨晓伟 王雷雨 胡春晖 赵先诚 邓鑫 张前进. 经尿道膀胱肿瘤切除术后尿道感染的病原菌特点及风险预测模型[J]. 临床外科杂志, 2026, 34(3): 331-336.
[9] 陈佳欣 李文 李玉倩 原雨梦 安美霞. 基于POSSUM系统、炎性因子对老年局部晚期食管鳞癌病人术后严重并发症的预测模型的构建与验证[J]. 临床外科杂志, 2026, 34(2): 139-144.
[10] 何风娟 张子怡 赵霞阳 孔雪. 基于Cox回归联合风险评分构建食管癌病人术后吻合口漏的预测模型[J]. 临床外科杂志, 2026, 34(2): 145-149.
[11] 孙苏阳, 丁国平, 孙秋明, 严旭. 重症颅脑损伤术后颅内感染病原菌分布及血清Clara细胞分泌蛋白16、细胞因子信号传导抑制因子-3预测颅脑感染的价值[J]. 临床外科杂志, 2026, 34(1): 42-45.
[12] 汪志鹏, 俞杰, 陆祥, 黄飞, 陈卫荣. 胸腔镜肺癌根治术病人隐匿性淋巴结转移的风险预测模型构建及分析[J]. 临床外科杂志, 2026, 34(1): 50-53.
[13] 喻先军, 胡蓉, 李晓娅, 赵思淳, 汪竹, 张定伟. 中性粒细胞胞外陷阱在老年髋部骨折病人术后肺炎的预测价值研究[J]. 临床外科杂志, 2026, 34(1): 86-89.
[14] 仵志远, 李华刚, 马卉. 动脉硬化闭塞症病人介入治疗后复发的预测模型构建[J]. 临床外科杂志, 2026, 34(1): 95-98.
[15] 徐锋 周心奇 高健扬. 腹腔镜直肠癌术后发生排尿功能障碍的危险因素分析及风险预测模型构建[J]. 临床外科杂志, 2025, 33(8): 813-817.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 涂儒鸿;黄昌明. 腹腔镜胃癌根治术淋巴结清扫技巧[J]. 临床外科杂志, 2016, 24(11): 809 .
[2] 陈凛;崔建新. 胃癌术后复发与再手术[J]. 临床外科杂志, 2016, 24(11): 813 .
[3] 杨钦;张再重;王烈. 空肠间置术在Siewert Ⅱ型食管胃结合部腺癌中的应用[J]. 临床外科杂志, 2016, 24(11): 816 .
[4] 应敏刚;杨春康. 腹腔镜胃癌根治术并发症的防治策略[J]. 临床外科杂志, 2016, 24(11): 819 .
[5] 石汉平. 胃癌围手术期营养治疗[J]. 临床外科杂志, 2016, 24(11): 821 .
[6] 吴川清;刘炜圳;帅晓明;等. 超声内镜在胃癌术前诊断中的应用分析[J]. 临床外科杂志, 2016, 24(11): 828 .
[7] 王维君;那光玮;何科基;等. 根治性淋巴结清扫联合脾切除在残胃癌手术中的临床意义探究[J]. 临床外科杂志, 2016, 24(11): 835 .
[8] 李晓辉;金太欣;邵永胜 . 升结肠回盲部肿瘤侵犯乙状结肠22例治疗体会[J]. 临床外科杂志, 2016, 24(11): 841 .
[9] 周振宇;汪路明;王一青;等. 肺部多发结节468例诊疗分析[J]. 临床外科杂志, 2016, 24(11): 865 .
[10] 张重捷;陈杰;邹奇;等. 两种微创手术治疗胆囊结石合并胆总管结石的临床效果比较[J]. 临床外科杂志, 2016, 24(11): 869 .